Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Acta Pharm Sin B. 2024 Jun;14(6):2790. doi: 10.1016/j.apsb.2024.02.014. Epub 2024 Feb 22.

¹ Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China.
² Department of Operational Medicine, Tianjin Institute of Environmental & Operational Medicine, Tianjin 300050, China.

Abstract

[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].